The Record

News for the Washington University Campuses & Community
Straight from The Source

Wednesday, March 7, 2018

Top Stories

CRISPR enhances cancer immunotherapy

The School of Medicine’s John DiPersio, MD, PhD, leads a team developing an “off-the-shelf” CAR-T immunotherapy for hard-to-treat T cell cancers. A new study evaluates the approach in mice with human T cell acute lymphoblastic leukemia.

Arms races and cooperation among amoebae in the wild

Using new gene sequencing techniques, biologists in Arts & Sciences are taking a closer look at the behavior of the social amoeba Dictyostelium discoideum, as reported in the Proceedings of the National Academy of Sciences.

Uncertainty leads to treatment delays for mentally ill youth

Stigmas, attitudes of self-reliance and misattributing symptoms led a group of young adults experiencing their first episode of psychosis to delay seeking treatment, a new Brown School study finds.

Read more stories on The Source →

Campus Announcements

Vote for med school team in STAT Madness

One research team at the School of Medicine made it to the second round of STAT Madness, a competition aimed at finding the best biomedical innovations of 2017. Online voting runs through tomorrow, March 8.

WashU in the News

Trump may have violated the law by reportedly putting presidential seal on golf tee markers


Getting a ‘like’ on Facebook won’t make you happy, says WashU psychologist

St. Louis Public Radio

Narcissism in the C-suite affects firms’ financial reports

St. Louis Post-Dispatch

See more WashU in the News →


Mark Anastasio, of the School of Engineering & Applied Science, has been appointed chair of the National Institutes of Health (NIH) Biomedical Imaging Technology B Study Section for a two-year term beginning July 1.

Read more Notables →

You have received this e-mail because you expressed interest in receiving updates from, the Record and its related products by e-mail. Thanks for your subscription. If you do not want to receive the Record via e-mail, you may unsubscribe. Got this as a forward? Sign up to receive our future e-mails.